Growth within the India Antibodies Market is characterized by a strong shift toward innovation and localized supply chains. As the demand for biologics grows, companies are moving away from traditional chemical-based drugs toward more precise, antibody-based therapies. This strategic pivot is supported by increased funding for biotech startups and a more robust intellectual property landscape...